校准二维超声无创分期肝脂肪变性:以肝活检为参考标准
本研究回顾性分析223例接受超声引导下肝活检患者的二维超声图像,使用校准超声(CAUS)半自动估计回声水平和纹理参数,重点评估残余衰减系数(RAC)。结果显示RAC与脂肪变性相关性最佳(R=0.78),检测脂肪变性AUC为0.97,预测中度和重度脂肪变性AUC均为0.93,且不受纤维化影响。
要点
- CAUS的RAC参数可准确检测和分期肝脂肪变性,观察者间相关性高(平均ICC 0.95)。
- RAC检测脂肪变性(>5%脂肪)的AUC为0.97,预测中度(>33%脂肪)和重度(>66%脂肪)脂肪变性的AUC均为0.93。
局限性
- 回顾性研究设计。
- 单中心研究。
- 训练集和测试集样本量较小(各约97例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Accumulation of lipid in the liver (ie, hepatic steatosis) is the basis of nonalcoholic fatty liver disease (NAFLD). Asymptomatic steatosis can lead to nonalcoholic steatohepatitis and downstream complications. Purpose To assess the diagnostic performance of calibrated US (CAUS) as a method for detection and staging of hepatic steatosis in comparison with liver biopsy. Materials and Methods Two-dimensional US images in 223 consecutive patients who underwent US-guided liver biopsy from May 2012 to February 2016 were retrospectively analyzed by two observers using CAUS. CAUS semiautomatically estimates echo-level and texture parameters, with particular interest in the residual attenuation coefficient (RAC), which is the remaining steatosis-driven attenuation obtained after correction of the beam profile. Data were correlated with patient characteristics and histologically determined steatosis grades and fibrosis stages. The data were equally divided into training and test sets to independently train and test logistic regression models for detection (>5% fat) and staging (>33% and >66% fat) of hepatic steatosis by using area under the receiver operating characteristic curve (AUC) analysis. Results A total of 195 patients (mean age, 50 years ± 13 [SD]; 110 men) were included and divided into a training set (n = 97 [50%]) and a test set (n = 98 [50%]). The average CAUS interobserver correlation coefficient was 0.95 (R range, 0.87-0.99). The best correlation with steatosis was found for the RAC parameter (R = 0.78, P < .01), while no correlation was found for fibrosis (R = 0.14, P = .054). Steatosis detection using RAC showed an AUC of 0.97 (95% CI: 0.94, 1.00), and the multivariable AUC was found to be 0.97 (95% CI: 0.95, 1.00). The predictive performance for moderate and severe hepatic steatosis using RAC was 0.93 (95% CI: 0.88, 0.98) and 0.93 (95% CI: 0.87, 0.98), respectively. Conclusion The calibrated US parameter residual attenuation coefficient detects and stages steatosis accurately with limited interobserver variability, and performance is not hampered by the presence of fibrosis. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Grant in this issue.
引用
- Weijers, Munsterman, Thijssen, et al. Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard. Radiology. 2022. PMID: 36255308. doi:10.1148/radiol.220104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。